Determining the Upgrade Rate of De-novo Breast Intraductal Papillomas to Malignancy, its Related Risk Factors, and 6-Month Outcome After Treatment
Indian Journal of Surgical Oncology · 2026-01 · 17 (1) · 96-103
DOI: 10.1007/s13193-025-02263-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Surgical Oncology, online erschienen am 22.04.2025. Verfasst von Parisa Aziminezhadan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Aziminezhadan Breast Clinic, Tehran, Iran. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Iran University of Medical Sciences.
Abstract (Originalsprache)
Intraductal papillomas (IDPs) are benign breast lesions with potential for malignant transformation. This study aimed to determine the upgrade rate of de-novo IDPs to malignancy, identify associated risk factors, and assess the 6-month outcome after treatment. This retrospective cohort study included 320 patients diagnosed with de-novo IDP at a breast surgery clinic in Tehran, Iran, between March 2011 and March 2022. Patients were divided into upgraded (malignant) and non-upgraded (benign) groups based on pathology results from core needle biopsy (CNB) or vacuum-assisted excision (VAE). Baseline characteristics, pathology outcomes, and follow-up outcomes were analyzed. Multivariable logistic regression identified risk factors for malignant upgrade. Of the 320 participants, 16 (5.0%) had upgraded (malignant) IDPs, and 304 (95.0%) had non-upgraded (benign) IDPs. The median age was significantly higher in the upgraded group (53 years) compared to the non-upgraded group (43 years) (p < 0.001). Age ≥ 50 years was a significant risk factor for malignant upgrade (, p < 0.001). The most common malignant pathology was ductal carcinoma in situ (DCIS) (68.8%). Age was identified as a significant risk factor for malignancy, with older age increasing the likelihood of an upgrade (OR = 1.249, p = 0.02). After 6 months follow-up, three patients with IDP were detected by sonography. Older age was the sole significant risk factor for malignant transformation of IDPs. Continuous follow-up is recommended, especially for older patients, to promptly detect potential recurrence or malignant progression.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Aziminezhadan Breast Clinic, Tehran, Iran.
- Deparment of General Surgery, School of Medicine, Tehran, Iran.
- Firoozabadi Clinical Research Development Unit (F A CRD U, School of Medicine, Tehran, Iran.
- International Campus, Tehran, Iran.
- Firoozabadi Clinical Research Development Unit ( F A CRD U, School of Medicine, Tehran, Iran.
ORCID-Profile: Parisa Aziminezhadan, Mahsa Jafari Harandi, Faranak Olamaeian, Mohammadjavad Ashoori, Ali Tayebi
Förderung
- Iran University of Medical Sciences
Zitieren
APA
Aziminezhadan, P., Harandi, M. J., Olamaeian, F., Ashoori, M., & Tayebi, A. (2026). Determining the Upgrade Rate of De-novo Breast Intraductal Papillomas to Malignancy, its Related Risk Factors, and 6-Month Outcome After Treatment. Indian Journal of Surgical Oncology, 17(1), 96-103. https://doi.org/10.1007/s13193-025-02263-2
Vancouver
Aziminezhadan P, Harandi MJ, Olamaeian F, Ashoori M, Tayebi A. Determining the Upgrade Rate of De-novo Breast Intraductal Papillomas to Malignancy, its Related Risk Factors, and 6-Month Outcome After Treatment. Indian Journal of Surgical Oncology. 2026;17(1):96-103. doi:10.1007/s13193-025-02263-2
BibTeX
@article{Aziminezhadan2026,
author = {Aziminezhadan, Parisa and Harandi, Mahsa Jafari and Olamaeian, Faranak and Ashoori, Mohammadjavad and Tayebi, Ali},
title = {Determining the Upgrade Rate of De-novo Breast Intraductal Papillomas to Malignancy, its Related Risk Factors, and 6-Month Outcome After Treatment},
journal = {Indian Journal of Surgical Oncology},
year = {2026},
volume = {17},
number = {1},
pages = {96--103},
doi = {10.1007/s13193-025-02263-2}
}
EUVIMED